Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: JAF who wrote (2214)	11/7/1997 4:13:00 PM
From: Mitchell D. Wilcox	Read Replies (1) \| Respond to of 23519

Thanks, can anyone account for the other 43%? Mitch

To: JAF who wrote (2214)	11/7/1997 4:59:00 PM
From: Vol	Respond to of 23519

Associated Press - November 7, 1997 New York (AP) - A twenty-three year old man killed in a car accident reportedly had taken Tylenol for a headache earlier that day. The FDA reportedly has cleared McNeil Consumer Products Company, the maker of Tylenol, from any wrong-doing. McNeil's stock, however, was sent reeling by Wall Street down by 10%. The stock was already down more than 40% in the previous weeks, presumably from knowledge of the incident by money managers and in-the-know Wall Street "Fat Cats". No one at McNeil was available for comment. "They are obviously up to something. I predict that the companies earnings will by slashed in half by next year, and their stock will be lucky to be worth 25% of it's high last month," commented an anonymous analyst. Rumor has it that Tylenol is to be pulled from the shelves by next week. Makes about as much sense, doesn't it? Vol

To: JAF who wrote (2214)	11/7/1997 9:43:00 PM
From: MisterED	Read Replies (1) \| Respond to of 23519

The old man died on Monday Oct.6, and the conference call took place after the close on Wednesday Oct.8. Vivus started to go down the next day. There were no negative news in the conference, and it seems very likely that some MMs got wind of his death and started selling in panic without at that time knowing the circumstances. After all he was part of the FDA study and quite a few people would know about it. The news release today explained the incident, and it is obvious that the guy died of a heart attack or stroke unrelated to Muse. The release came out just before the market closed, and we saw a one point uptick in just a few minutes. Just before Vivus was down 1 3/4. I think this has been overhanging the stock all these weeks and we have finally cleared the air.